Skip to content

Soybean Oil

  • Prescription medicine
  • Prescription only
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Soybean Oil does in the body

Nutrilipid 20% causes an increase in heat production, decrease in respiratory quotient, and increase in oxygen consumption following its administration.

From the FDA-approved label: Nutrilipid 20% administered intravenously provides biologically utilizable source of calories and essential fatty acids. Fatty acids serve as an important substrate for energy production. The most common mechanism of action for energy production derived from fatty acid metabolism is beta oxidation. Fatty acids are important for membrane structure and function, precursors for bioactive molecules (such as prostaglandins), and as regulators of gene expression.

Why people take it. Intralipid ® is indicated as a source of calories and essential fatty acids for adult and pediatric patients requiring parenteral nutrition and as a source of essential fatty acids for prevention of essential fatty acid deficiency (EFAD).

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
Professional supervision is normally required. A regulator classifies this substance in a way that restricts how it is supplied.

What the registries record it as

  • The substance registry classes this as structurallydiverse.

    FDA substance registry · 241ATL177A · read 2026-08-29

  • It is recorded as coming from GLYCINE MAX WHOLE. The part recorded is seed.

    FDA substance registry · 241ATL177A · read 2026-08-29

  • The organism is Glycine max, a species. It is also called soybean and soybeans.

    NCBI Taxonomy · 3847 · read 2026-08-29

  • The supplement label database classes it as botanical, under the name Soybean Oil.

    NIH Dietary Supplement Label Database · 1164 · read 2026-08-29

Where each sentence above came from

A person wrote this explanation into the record, with the studies named in the path below.

The use the label states, quoted from it. It is written for a clinician, not for a reader without medical training.

No statement of the main limit is recorded.

The four opening statements run to 134 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Stand-in result

A stand-in result is a number measured because the real result takes too long.

A picture of it, and where the picture fails

It is like judging a journey by the speedometer rather than by arriving.

Where that stops being true. Speed does predict arrival. Many stand-in results do not predict the real one.

What people get wrong. A stand-in result is often reported as the result itself.

A surrogate endpoint substituted for a clinical endpoint, valid only where the substitution has been shown to hold.

Enzyme

An enzyme is a protein that speeds up one chemical change.

A picture of it, and where the picture fails

An enzyme is like a machine on a production line doing one cut.

Where that stops being true. A machine is switched on and off by a person. Enzymes are controlled by the cell.

What people get wrong. Enzymes are thought to be used up. They are not; they work again and again.

A catalytic protein that lowers the activation energy of a specific reaction.

Receptor

A receptor is a part of a cell that a signal fits into.

A picture of it, and where the picture fails

A receptor is like a lock waiting for one key.

Where that stops being true. A lock either opens or does not. A receptor can be half-triggered, or worn out.

What people get wrong. Fitting a receptor is read as causing a benefit. It causes a step, and nothing more.

A protein that binds a specific ligand and converts that binding into a cellular response.

Pathway

A pathway is a chain of steps inside a cell, each one setting off the next.

A picture of it, and where the picture fails

A pathway is like a row of dominoes.

Where that stops being true. Dominoes fall one way. Pathways loop back and can switch themselves off.

What people get wrong. Changing one step is read as changing the outcome. Other steps often absorb it.

An ordered series of molecular interactions producing a defined cellular change.

What happened in peopleRead from sources, not yet reviewed

What was measured, goal by goal

One row for each goal a registered study measured something for. One column for each kind of thing that could be measured.

Registered studies list 40 outcome measures that RNAWiki could read. A registered study says what someone planned to measure. It does not say what they found. 0 of the matched studies tested this substance, and 0 posted a result.

There is no single score. A strong test result and a weak life result are different facts.

Goals down the side, kinds of measurement across the top. Each cell says what kind of thing was registered, not what was found.
GoalLife outcomeWhat a body can doHow a person feelsA test resultA step in the bodyHarmsHow longWho was studied
CholesterolNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Only a number moved1 registered test measure.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
Blood sugarNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Only a number moved1 registered test measure.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
Which registered measures put each goal on this table
Cholesterol
serum triglyceride level; lipid profile
Blood sugar
muscle insulin sensitivity m value

Sorted by fixed word lists, version v1. A name the rules do not recognise stays unsorted rather than moving to the nearest column.

What each mark on this table means
Nothing in the sources checked
No registered study lists a life outcome for this goal.
Only a number moved
1 registered test measure.
Not recorded
Harms were not a registered measure for this goal.
Waiting for a reviewer
Who was studied is listed further down the page.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Risk of death

The study did not show it

Who was studied
NCT01138449
How many people
44984
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
Living longer, or avoiding a major event
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Injection

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

24-week infant mortality rate

The study did not show it

Who was studied
NCT00128557
How many people
15937
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
Living longer, or avoiding a major event
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Injection

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

Programmatic recovery by 12 weeks from admission

The study did not show it

Who was studied
NCT06382857
How many people
7356
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Injection

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

Change in average percent of oil by volume in the porridge as prepared

The study did not show it

Who was studied
NCT01873196
How many people
6811
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Injection

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

Stunting in Children at 18 mo

The study did not show it

Who was studied
NCT01562379
How many people
5449
Study design
Phase 2/Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Injection

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

Changes in mean hemoglobin concentrations

The study did not show it

Who was studied
NCT02567981
How many people
4577
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Injection

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What happened in peopleRead from sources, not yet reviewed

How close this is to real life

The top step is something a person would feel or care about. The bottom is a guess from software. Filled steps are where evidence exists for this substance.

  1. Living longer, or avoiding a major event No evidence recorded. Death, a heart attack, a stroke, a hospital stay.0 registered measures of this kind. 1 written-up study measured this and did not show a benefit.
  2. What a body can do day to day No evidence recorded. Walking, dressing, breathing, recovering.No registered study measures this.
  3. Measured performance No evidence recorded. How much was lifted, how far was run, how fast.No registered study measures this.
  4. Symptoms and quality of life No evidence recorded. Pain, tiredness, mood, sleep, as the person rated it.No registered study measures this.
  5. A number that stands in for health Evidence recorded. Cholesterol, blood sugar, bone density. A stand-in, not the thing itself.10 registered measures of this kind.
  6. A step measured inside a person Evidence recorded. Something measured in human tissue or human cells.1 registered measure inside human tissue.
  7. Animals Evidence recorded. Mice, rats, dogs. Useful for ideas, not proof about people.Stored records in Mouse, Rat. A result in animals says what to test next. It does not say what happens in people.
  8. Cells in a dish Evidence recorded. Cells or chemistry on a bench, far from a whole body.Stored mechanism abstracts describe steps measured in cells or tissue.
  9. A guess from software No evidence recorded. Nobody measured it. RNAWiki never publishes one as a finding.RNAWiki stores no prediction for this record. Software can suggest a link. RNAWiki does not publish one as a finding.

Higher on these steps means closer to something a person would feel. It does not mean better done.

What it would be like to takeRead from sources, not yet reviewed

Felt, measured, or meaningful

Three different things that get called the same word. Registered studies measured all three, and mixing them is how a blood test becomes a health claim.

Felt

Things a person could notice without a test.

No registered study measured anything of this kind.

Measured

Things only a test, a scale or a device shows.

  • serum triglyceride level
  • systemic inflammatory response syndrome
  • circulating serum interleukin 6
  • c reactive protein
  • serum conjugated bilirubin
  • flow mediated dilation of brachial artery
  • muscle insulin sensitivity m value
  • liver function
  • total cerebral white matter hyperintensity volume
  • flow mediated dilation

and 1 more.

Meaningful

Things that change how a life goes, not only a number.

No registered study measured anything of this kind.

A registered study says what someone planned to measure. It does not say what they found. A number moving is not the same as a life going better. The two are shown apart here.

Felt, but not shown to help. A person notices a change. No study showed it leads anywhere good.

Measured, but not felt. A number moves. The person notices nothing. Both can be true.

Measured, but not shown to matter. A number moves in the good direction. Nobody showed that lives went better.

Matters, but takes years. The result that counts may take longer than anyone would keep watching.

Names that fit none of the three (29)
  • negative affect
  • impulsivity
  • aggression
  • hostility barefoot
  • trait anger
  • anger expression
  • type a total
  • apolipoprotein a i level
  • circulating glucagon like peptide 1 levels
  • circulating gastric inhibitory polypeptide levels
  • circulating ghrelin levels
  • circulating peptide tyrosine tyrosine levels
  • clinical pregnancy rate
  • incidence of parenteral nutrition associated cholestasis
  • chemical pregnancy rate
  • retinopathy of prematurity
  • prealbumin
  • study related serious adverse events
  • study related unanticipated adverse events
  • evidence of fat embolism

These are harms, study-process measures, or names the rules did not recognise. They are shown rather than dropped.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

People similar to this profile were included.

  • Nutrilipid ® 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition is not possible, insufficient, or contraindicated.

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What the label states about particular groups

  • On pediatric, the label states: “Intralipid is contraindicated in pediatric patients with severe disorders of lipid metabolism [ (see Contraindications ( 4 )].”

    US prescribing information · 98460eae-5195-48d2-ab73-00d276879ef6 · read 2026-08-30

  • On older people, the label states: “Reported clinical experience has not identified differences in responses between the elderly and younger patients.”

    US prescribing information · 98460eae-5195-48d2-ab73-00d276879ef6 · read 2026-08-30

  • On people who are pregnant, the label states: “Risk Summary Administration of the recommended dose of Intralipid is not expected to cause major birth defects, miscarriage, or other adverse maternal or fetal outcomes.”

    US prescribing information · 98460eae-5195-48d2-ab73-00d276879ef6 · read 2026-08-30

  • On people who are breastfeeding, the label states: “Risk Summary Administration of the recommended dose of Intralipid is not expected to cause harm to a breastfed infant.”

    US prescribing information · 98460eae-5195-48d2-ab73-00d276879ef6 · read 2026-08-30

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied for a different goal

The studies measured something else entirely.

On this record: Some registered studies measured things that match no goal on this page.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (10)
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Prescription only

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Injection

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form and route recorded on this substance.

No source is stored against this line.

Who oversees it

Professional supervision is normally required. A regulator classifies this substance in a way that restricts how it is supplied.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Suppression classes recorded: S6.

No source is stored against this line.

What is in the pack

Sold as injectable, emulsion, injection, emulsion, injection, solution, given by the injection, intravenous route.

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

Recorded notes on how this is sold and what that means for what is in the pack.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Reports sent to a regulator

  • These are reports people sent to a regulator. They do not show the medicine caused the reaction.
  • Nobody counted how many people took the medicine and reported nothing.
  • The same event can be reported more than once, and many reports are incomplete.
  • News coverage, lawsuits and new warnings change how often people report.
  • A count is not a rate and not a risk.

Soybean Oil appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 549 reaction mentions were counted. One report can name several reactions.

The recorded terms (10)
  • chills — 162 reaction mentions
  • pyrexia — 129 reaction mentions
  • parenteral nutrition associated liver disease — 64 reaction mentions
  • chest discomfort — 43 reaction mentions
  • hyperpyrexia — 36 reaction mentions
  • fatty acid deficiency — 27 reaction mentions
  • palpitations — 25 reaction mentions
  • temperature intolerance — 22 reaction mentions
  • hypertriglyceridaemia — 21 reaction mentions
  • cholestasis — 20 reaction mentions
  • open-targets-adr · recorded 2026-06-24 · a recorded source, not a stored snapshot

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Injection

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form used in the studies cited on this page.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • 20 products list this as an active ingredient in the United States drug directory. 16 of them contain it and nothing else.

    FDA National Drug Code directory · 0264-4460 · read 2026-08-29

  • They are sold as emulsion, injection, emulsion, injection, solution and oil, taken intravenous.

    FDA National Drug Code directory · 0264-4460 · read 2026-08-29

  • The regulator's established pharmacologic class for it is lipid emulsion [epc] and lipids [cs].

    FDA National Drug Code directory · 0264-4460 · read 2026-08-29

  • 15 published labels name it as an active ingredient. 11 of them describe this substance alone, which is where its own label text on this page comes from.

    US prescribing information · afeb4837-a759-4484-a76e-e04611c459e7 · read 2026-08-29

  • Those labels are classed as human prescription drug.

    US prescribing information · afeb4837-a759-4484-a76e-e04611c459e7 · read 2026-08-29

  • Intralipid is intravenous at 3 DOSAGE FORMS AND STRENGTHS Intralipid 30% is a sterile, homogenous, milky, white lipid injectable emulsion in Flexible Containers supplied as: • 150 g/500 mL (0.3 g/mL) of lipid in 500 mL Pharmacy Bulk Package 30% Inj…, recorded as fda label in effect 2025-10-09 in the United States.

    US prescribing information · 98460eae-5195-48d2-ab73-00d276879ef6 · read 2026-08-30

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.

Self-experiment planning is not offered for a prescription or clinician-supervised medicine. The questions below are for a clinician or pharmacist.

Questions worth asking

  • Which of the trials of Soybean Oil studied people like me?
  • What was measured, and for how long?
  • Was the result a laboratory value or a health outcome?
  • What would we watch for, and when would we stop?

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki records evidence. It does not say whether this substance is right for you.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

How fast does the body clear it?

The sources RNAWiki checked hold nothing for this field.

Why it matters. Without this, nothing on this page can say how long anything lasts.

What would answer it

A stored source that records it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Soybean Oil are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleRead from sources, not yet reviewed

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Where else this substance is registered

FDA substance identifier (UNII)
241ATL177A
RxNorm concept
200317

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Passed

    Every public sentence names a source

    The opening statement carries the origin: Written into the record, not signed off.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Passed

    Safety mode resolved

    Suppression classes recorded: S6.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

How this medicine reached us

Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.

What the approval register records

  • 17 approved applications cover products containing this substance. The earliest was NDA017643, approved 19751007 to FRESENIUS.

    Drugs@FDA application register · NDA017643 · read 2026-08-29

  • Marketing status on the register: discontinued and prescription.

    Drugs@FDA application register · NDA017643 · read 2026-08-29

  • The earliest marketing start date recorded for a listed product is 20040401.

    FDA National Drug Code directory · 0264-4460 · read 2026-08-29

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

6 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • The path through the body — found nothing in the sources checked.
  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (11)

What did Soybean Oil's largest trial (406 people) and its longest (12 years) measure?


406 people in Soybean Oil's largest registered study, 12 years in its longest registered window, measuring Concentrations of IL-6 measured in effluent samples from subcutaneous tissue. ClinicalTrials.gov · 2026-09-01

36 na, 19 phase4, 16 phase2, 11 phase3, 8 phase1, 3 early phase1; NCT02647723; 2027-12-31. Last human test completed 2025, NCT06247930.

Interpretation These counts include studies where Soybean Oil was a comparison treatment, a background treatment or an exposure in an observational study, and the longest window may be a planned end date. Trial roles have not yet been classified for this record.

Show the evidence
  • na
    36
  • phase4
    19
  • phase2
    16
  • phase3
    11
  • phase1
    8
  • early phase1
    3
1 more recorded row
  • Last recorded human test NCT06247930
    2025-06-24

recorded 2026-09-01 · last checked 2026-09-04

From mouse to human: where has Soybean Oil shown lifespan?


mouse: mechanism-only, rat: lifespan and human: biomarker (87): the rungs where Soybean Oil has a recorded finding. Europe PMC and ClinicalTrials.gov · organism ladder · 2026-09-01

Concentrations of IL-6 measured in effluent samples from subcutaneous tissue. — the recorded outcome words.

Yeast C. elegans Drosophila Mouse mechanism-onlyRat lifespanDog Non-human primate Human biomarker
Show the evidence
  • mouse
    mechanism-only
  • rat
    lifespan
  • human NCT00708266
    biomarker; Concentrations of IL-6 measured in effluent samples from subcutaneous tissue.; 87

recorded 2026-09-01 · last checked 2026-09-04

16 of Soybean Oil's trials stopped: futility/efficacy, accrual/recruitment, funding/business, other?


futility/efficacy (2), accrual/recruitment (4), funding/business (1) and other (9): Soybean Oil's stop wording, clustered. ClinicalTrials.gov · 2026-09-01

"Manufacturing change in one of the two lipid emulsion products being studied."; 16 of 87 registered studies

Show the evidence

Trial

  • NCT00278928
    terminated; "Manufacturing change in one of the two lipid emulsion products being studied."
  • NCT01096446
    terminated; "To many infants in the experimental group developed hypertriglyceridemia"
  • NCT01096771
    terminated; "Unable to secure product from international source, low recruitment rate."
  • NCT01175330
    terminated; "Interim analysis did not reveal of anticipated benefits of intervention"
  • NCT01373918
    terminated; "The study was terminated due to slow enrollment."
  • NCT01565278
    terminated; "No more eligible patients could be identified."
10 further recorded trials
  • NCT02463812
    withdrawn; "No participants enrolled"
  • NCT02476994
    terminated; "Based on feedback from FDA"
  • NCT02579265
    terminated; "Outcome of a planned interim analysis was that the sample size required to show superiority was too high to be feasible. Fresenius Kabi requested termination to the FDA on 17 Jan 2020. FDA accepted termination by written response on 16 Apr…"
  • NCT02722902
    terminated; "No effect of carnitine on lipid induced insulin resistance after n=8 (p=1.00)"
  • NCT03122912
    terminated; "Enrollment and interactions/interventions paused due to COVID-19. Not expected to resume in the future. This is not a suspension of IRB approval"
  • NCT03127345
    withdrawn; "Lack of funding"
  • NCT03563222
    terminated; "Prematurely stopped in agreement with authorities (FDA)"
  • NCT03998709
    withdrawn; "results from other study suggest no good reason to proceed"
  • NCT04120220
    terminated; "PI will be retiring from the Center. Research will not continue with a new PI."
  • NCT04592380
    withdrawn; "Product was divested to Chiesi USA, who decided to not move forward with study."

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Soybean Oil used Liposyn III 20% (lipid infusion) — over how long?


studies of Soybean Oil used the recorded amount. ClinicalTrials.gov · 2026-09-01

14 recorded entries; human; infusion, intravenous; also "Liposyn III 20% (lipid infusion)", "Intralipid 20% (lipid infusion)", "Intralipid 20%"

Show the evidence

human

  • NCT00278928
    infusion; Liposyn III 20% (lipid infusion)
  • NCT00278928
    infusion; Intralipid 20% (lipid infusion)
  • NCT00708266
    Intralipid 20%
  • NCT01115179
    Intralipid 10%
  • NCT01284049
    Intralipid 20%®
  • NCT01540591
    intralipid 20%
8 more recorded rows
  • human NCT02240498
    20% I.V. Fat Emulsion
  • human NCT02462772
    Intralipid® 20%
  • human NCT02579265
    intravenous; Intralipid® 20% (a 20% intravenous fat emulsion)
  • human NCT03132779
    Intralipid 18 mg
  • human NCT03563222
    Intralipid, 20%
  • human NCT03563222
    Intralipid® 20% (20% i.v. fat emulsion)
  • human NCT03968822
    Intralipid, 20% Intravenous
  • human NCT04807634
    Intravenous Lipid Emulsion (Intralipid 20%)

recorded 2026-09-01 · last checked 2026-09-04

Which of adverse events, aggression and anger expression did Soybean Oil's trials measure?


adverse events, aggression and anger expression lead 40 outcome terms across Soybean Oil's trials. ClinicalTrials.gov · 2026-09-01

Interpretation c reactive protein, negative affect, impulsivity, aggression, hostility barefoot and trait anger follow.

Show the evidence
  • serum triglyceride level
    1
  • systemic inflammatory response syndrome
    1
  • circulating serum interleukin 6
    1
  • c reactive protein
    1
  • negative affect
    1
  • impulsivity
    1
14 more recorded rows
  • aggression
    1
  • hostility barefoot
    1
  • trait anger
    1
  • anger expression
    1
  • type a total
    1
  • serum conjugated bilirubin
    1
  • flow mediated dilation of brachial artery
    1
  • apolipoprotein a i level
    1
  • circulating glucagon like peptide 1 levels
    1
  • circulating gastric inhibitory polypeptide levels
    1
  • circulating ghrelin levels
    1
  • circulating peptide tyrosine tyrosine levels
    1
  • clinical pregnancy rate
    1
  • incidence of parenteral nutrition associated cholestasis
    1

recorded 2026-09-01 · last checked 2026-09-04

Which of Soybean Oil's 7 ongoing trials reports first?


7 registered trials of Soybean Oil are open; earliest completion 2026-10. ClinicalTrials.gov · 2026-09-01

Average Change in Perceived Stress Scale (PSS) Score From Visit 1 to Visit 4; Change in LH Pulse Amplitude Before and After Acute or Chronic FFA Administration; latest 2031-06-30

Show the evidence

Trial

  • NCT02647723
    "Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation"; n 168; "Average Change in Perceived Stress Scale (PSS) Score From Visit 1 to Visit 4"; 2027-12-31
  • NCT02653092
    "Reprometabolic Syndrome Mediates Subfertility in Obesity"; n 84; "Change in LH Pulse Amplitude Before and After Acute or Chronic FFA Administration"; 2026-12-11
  • NCT03818178
    "Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids"; n 60; "Change in fatty acid enrichment of intramyocellular signaling molecules before and after a euglycemic, hyperinsulinemic clamp"; 2026-12
  • NCT03968822
    "Intralipid® 20% for Reversal of Local Anesthetics"; n 18; "Time to complete normal sensation after lidocaine 1%"; 2026-10
  • NCT04832009
    "Reversing Glucose and Lipid-mediated Vascular Dysfunction"; n 46; "Efficacy of Infusion of Ascorbic Acid"; 2027-08-01
  • NCT06052956
    "Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses"; n 120; "Time to removal of the drainage catheter"; 2031-06-30
  • 1 further recorded trial NCT07462013
    "Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice"; n 120; "Depressive Symptoms"; 2028-09

recorded 2026-09-01 · last checked 2026-09-04

Which running trial of Soybean Oil could settle insulin sensitivity?


NCT03818178 measures Change in fatty acid enrichment of intramyocellular signaling molecules before and after a euglycemic, hyperinsulinemic clamp, reading out 2026-12.

1 open trial; n 60; "Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids"

Show the evidence
  • Trial NCT03818178
    "Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids"; n 60; "Change in fatty acid enrichment of intramyocellular signaling molecules before and after a euglycemic, hyperinsulinemic clamp"; 2026-12

Which 29 trials of Soybean Oil posted no result?


Posted no result
29 of 29 completed trials
Registrations
NCT00292279, NCT01115179, NCT00708266, NCT00579540, NCT01006174 and NCT01028274, and 23 more
Completion dates
oldest 2004-02; newest 2023-09
Show the evidence

Trial

  • NCT00292279
    2004-02
  • NCT01115179
    2005-12
  • NCT00708266
    2007-04
  • NCT00579540
    2009-09
  • NCT01006174
    2010-05
  • NCT01028274
    2010-08
14 further recorded trials
  • NCT00512629
    2011-12
  • NCT01250275
    2013-02
  • NCT01602250
    2013-08
  • NCT00829699
    2014-04
  • NCT01540591
    2014-06
  • NCT02487940
    2015-04
  • NCT02349594
    2015-09
  • NCT02599103
    2015-09
  • NCT02404207
    2015-10
  • NCT01284049
    2016-03
  • NCT01788540
    2016-09
  • NCT02771912
    2017-02-21
  • NCT02924454
    2017-03-10
  • NCT03374163
    2017-06-30

At the median, Soybean Oil's trials enrolled 36 people — anything larger?


Median enrolment
36
Largest enrolment
406
Registered trials counted
87

What do 549 spontaneous reports say about Soybean Oil — and not say?


These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.

Soybean Oil appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 549 reaction mentions were counted: chills 162; pyrexia 129; parenteral nutrition associated liver disease 64; chest discomfort 43. open-targets-adr · CHEMBL1201485 · 2026-06-24

Show the evidence
  • chills
    162
  • pyrexia
    129
  • parenteral nutrition associated liver disease
    64
  • chest discomfort
    43
  • hyperpyrexia
    36
  • fatty acid deficiency
    27
4 more recorded rows
  • palpitations
    25
  • temperature intolerance
    22
  • hypertriglyceridaemia
    21
  • cholestasis
    20

recorded 2026-06-24 · last checked 2026-09-04

What is recorded about Soybean Oil and AMPK?


"Further analysis indicated that activation of the AMPK pathway contributes to these observed phenotypes, and co-upregulated of glucagon and GLP-1 in mice fed with mixture of lard and soybean oil may contribute to improved lipids metabolism. <bold>Conclusion:</bold> Moderate lard intake—blended lard with vegetable oil especially soybean…" — where Soybean Oil and AMPK appear together. Europe PMC · pathway abstract search · 2021-10-20

AMPK, NAD+; PMID 1880630

Show the evidence
  • AMPK
    "Further analysis indicated that activation of the AMPK pathway contributes to these observed phenotypes, and co-upregulated of glucagon and GLP-1 in mice fed with mixture of lard and soybean oil may contribute to improved lipids metabolism. <bold>Conclusion:</bold> Moderate lard intake—blended lard with vegetable oil especially soybean oil—has the potential to alleviate metabolic syndrome via…"
  • NAD+ PMID 1880630
    "The effects of dietary protein and soybean oil on the metabolism of L-tryptophan through the NAD pathway and the activity of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD) [EC4.1.1.45] in rat liver and kidney were investigated."

recorded 2021-10-20 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

ChEMBL id
CHEMBL1201485
CAS number
8001-22-7
RxCUI
9949
Also called
Glycine max seed oil, Intralipid (fresenius), Liposyn (hospira), Nutrilipid (b braun), Soybean oil, refined, omega-6, Black Soybean Oil, DOLICHOS SOJA SEED OIL, GLYCINE ANGUSTIFOLIA SEED OIL, GLYCINE GRACILIS SEED OIL, GLYCINE HISPIDA SEED OIL, GLYCINE MAX (SOYBEAN) OIL
Trade name
Soybean oil component of endolipide soya oil, Soybean oil component of smoflipid, Intralipid 20%, Soyacal 10%, Soyacal 20%, Intralipid 10%, Liposyn III 20%, NutriLipid I.V. Fat Emulsion, Intralipid / Intralipid 20% / Soyacal 10% / Soyacal 20% / Intralipid 10% / Liposyn III 20%, ENDOLIPIDE COMPONENT SOYA OIL
Salt form
I.V. FAT EMULSION
Sources (9)

Sources

  • ClinicalTrials.gov clinicaltrials.gov ·
  • ClinicalTrials.gov ClinicalTrials.gov API v2 snapshot 2026-09-01T09:00:05 ·
  • this record's own fields 2,3,5 ·
  • Europe PMC dose-response search ·
  • Europe PMC pathway abstract search ·
  • Europe PMC search ·
3 more sources

ClinicalTrials.gov — US Government work · Europe PMC — metadata only, under the recorded legal gate · Open Targets 26.06 — CC0 · derived from this page's own recorded fields; no external licence · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 5 required field(s) not terminal: Why people use it, Best-supported result, Most important common problem, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 9 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.